| I-66 Anders Kristoffersson Design and Interim Evaluation of a Sparse Sampling Schedule for Estimation of Individual Colistin Pharmacokinetics Wednesday 10:20-11:40 |
| II-09 Claire Ambery Balancing efficacy and risk: A case study of Phase 2 dose selection for an anti-inflammatory drug Wednesday 15:10-16:30 |
| II-68 Ivan Demin Guidance on dose-finding studies for biostatisticians and pharmacometricians: a Pharmacometrics perspective Wednesday 15:10-16:30 |
| III-01 Giulia Lestini Model-based optimal robust design in pharmacometrics Thursday 10:05-11:30 |
| III-25 Shuhua Hu Use of interim analysis to improve efficiency of clinical trial simulations in treatment comparison trial design studies Thursday 10:05-11:30 |
| III-33 Karin Nelander Longitudinal dose-response modelling as primary analysis of a clinical study Thursday 10:05-11:30 |
| III-46 Nathalie Perdaems PK/PD modelling: a usefull tool to train people to better design in vivo chronic study in ob/ob mice Thursday 10:05-11:30 |
| III-50 Caroline Petit Early phase dose-finding designs for bridging studies in pediatrics Thursday 10:05-11:30 |
| IV-74 Meng Zhaoling Program-wise trial simulation assessing design and analysis options from proof of concept to dose ranging Thursday 14:40-16:00 |
